225
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Treatment of rapidly progressive systemic sclerosis: current and futures perspectives

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christina G. Katsiari, Theodora Simopoulou, Ioannis Alexiou & Lazaros I. Sakkas. (2018) Immunotherapy of systemic sclerosis. Human Vaccines & Immunotherapeutics 14:11, pages 2559-2567.
Read now

Articles from other publishers (15)

Mingtao Liu, Zhangkai J. Cheng, Mingshan Xue, Runpei Lin, Teng Zhang & Baoqing Sun. (2023) The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases. Precision Medical Sciences.
Crossref
Yimin Yao, Alison Findlay, Jessica Stolp, Benjamin Rayner, Kjetil Ask & Wolfgang Jarolimek. (2022) Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis. International Journal of Molecular Sciences 23:10, pages 5533.
Crossref
Francesco Zulian, Roberto Dal Pozzolo, Alessandra Meneghel, Biagio Castaldi, Renzo Marcolongo, Alida Linda Patrizia Caforio & Giorgia Martini. (2020) Rituximab for rapidly progressive juvenile systemic sclerosis. Rheumatology 59:12, pages 3793-3797.
Crossref
Amin M. Cheikhi, Zariel I. Johnson, Dana R. Julian, Sarah Wheeler, Carol Feghali-Bostwick, Yvette P. Conley, James Lyons-Weiler & Cecelia C. Yates. (2020) Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index. PLOS ONE 15:10, pages e0240986.
Crossref
N. V. Goncharov, P. I. Popova, P. P. Avdonin, I. V. Kudryavtsev, M. K. Serebryakova, E. A. Korf & P. V. Avdonin. (2020) Markers of Endothelial Cells in Normal and Pathological Conditions. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 14:3, pages 167-183.
Crossref
Fabian A. Mendoza, Cathy Lee-Ching & Sergio A. Jimenez. (2020) Recurrence of progressive skin involvement following discontinuation or dose reduction of Mycophenolate Mofetil treatment in patients with diffuse Systemic Sclerosis. Seminars in Arthritis and Rheumatism 50:1, pages 135-139.
Crossref
Barbara Rindlisbacher, Cornelia Schmid, Thomas Geiser, Cédric Bovet & Manuela Funke-Chambour. (2018) Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC. Respiratory Research 19:1.
Crossref
Alexandre T. J. Maria, Karine Toupet, Marie Maumus, Pauline Rozier, Marie-Catherine Vozenin, Alain Le Quellec, Christian Jorgensen, Danièle Noël & Philippe Guilpain. (2018) Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells. Frontiers in Immunology 9.
Crossref
Peter J Wermuth, Sonsoles Piera-Velazquez & Sergio A Jimenez. (2018) Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis. Rheumatology 57:10, pages 1698-1706.
Crossref
Barbara Mara Klinkhammer, Jürgen Floege & Peter Boor. (2018) PDGF in organ fibrosis. Molecular Aspects of Medicine 62, pages 44-62.
Crossref
Peter J. Wermuth, Sonsoles Piera-Velazquez, Joel Rosenbloom & Sergio A. Jimenez. (2018) Existing and novel biomarkers for precision medicine in systemic sclerosis. Nature Reviews Rheumatology 14:7, pages 421-432.
Crossref
Takahiro Ueda, Takuro Sakagami, Toshiaki Kikuchi & Toshinori Takada. (2018) Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis. Respiratory Investigation 56:1, pages 14-20.
Crossref
Haralampos M. Moutsopoulos, Evangelia Zampeli & Panayiotis G. VlachoyiannopoulosHaralampos M. Moutsopoulos, Evangelia Zampeli & Panayiotis G. Vlachoyiannopoulos. 2018. Rheumatology in Questions. Rheumatology in Questions 153 175 .
Nikolay V. Goncharov, Alexander D. Nadeev, Richard O. Jenkins & Pavel V. Avdonin. (2017) Markers and Biomarkers of Endothelium: When Something Is Rotten in the State. Oxidative Medicine and Cellular Longevity 2017, pages 1-27.
Crossref
Sally Suliman, Abdalhamid Al Harash, William Neil Roberts, Rafael L. Perez & Jesse Roman. (2017) Scleroderma-related interstitial lung disease. Respiratory Medicine Case Reports 22, pages 109-112.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.